Skip to content

Effect of dietary intervention based on dietary inflammation index on improving pain in patients with rheumatoid arthritis

Effect of dietary intervention based on dietary inflammation index on improving pain in patients with rheumatoid arthritis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119311
Enrollment
Unknown
Registered
2026-02-25
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

Group A (Control group):Conventional medication therapy + conventional nursing care. Patients with initial diagnosis of rheumatoid arthritis (RA) who have received disease-modifying antirheumatic drug
Group B (Intervention Group):In addition to the control group, dietary intervention based on the Dietary Inflammation Index (DII) was implemented. Under the guidance of a clinical dietitian, low-DII d

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. Meeting the 2010 American College of Rheumatology/European Anti-Rheumatic League (ACR/EUR) criteria for rheumatoid arthritis; 3. Currently receiving disease-modifying anti-rheumatic drugs (DMARDs) with a treatment duration of >=3 months and stable therapeutic regimen; 4. No cognitive or communication impairments, capable of normal communication; 5. Informed consent obtained from patients, who voluntarily signed the informed consent form to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Non-rheumatoid pain disorders: such as osteoarthritis, gout, herpes zoster, chronic low back pain, non-rheumatoid autoimmune diseases, and other conditions that may independently cause joint/systemic pain; 2. Presence of severe underlying diseases: including allergies, asthma, cancer, Alzheimer's disease, severe hepatic/renal insufficiency, heart failure, and severe cardiopulmonary diseases. 3. Acute/chronic pain events occurring within the past 1 month: including fractures, trauma, surgery, and other acute/chronic pain events unrelated to RA pain that may confound the assessment of intervention efficacy. 4. Patients with a dietary inflammation index result <0; 5. Pregnant or lactating women; 6. Patients who are clearly unable to adhere to an anti-inflammatory diet due to factors such as religious beliefs, taste preferences, or economic conditions (e.g., complete avoidance of fish or refusal of vegetables); 7. Patients who have followed a prescribed dietary plan within the past 1 month (any prescribed dietary plan provided by a nutritionist or any diet restricting certain types of food, such as fasting, ketogenic diet, vegetarian diet, etc.); 8. Patients currently participating in or who have participated in other relevant clinical studies.

Design outcomes

Primary

MeasureTime frame
Pain intensity in RA patients;

Secondary

MeasureTime frame
Overall pain status in RA patients;Disease activity;Quality of life;Anxiety and depression status;Dietary adherence;

Countries

China

Contacts

Public ContactMa Shu

The First Hospital of Jilin University

mashu@jlu.edu.cn+86 135 0470 6660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026